Amyris, Inc. (AMRS)
(Delayed Data from NSDQ)
$5.04 USD
+0.60 (13.51%)
Updated May 3, 2019 04:00 PM ET
After-Market: $5.05 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$5.04 USD
+0.60 (13.51%)
Updated May 3, 2019 04:00 PM ET
After-Market: $5.05 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Ingevity (NGVT) Meets Q2 Earnings Estimates
by Zacks Equity Research
Ingevity (NGVT) delivered earnings and revenue surprises of 0% and 0.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Amyris (AMRS) Q1 Earnings In Line, Revenues Beat Estimates
by Zacks Equity Research
Amyris (AMRS) sees lower sales in its Consumer and Technology Access segments in the first quarter.
Amyris, Inc. (AMRS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of 0% and 0.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Mativ Holdings (MATV) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Mativ Holdings (MATV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amyris, Inc. (AMRS) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Amyris, Inc. (AMRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PPG Industries (PPG) Q1 Earnings Top Estimates
by Zacks Equity Research
PPG Industries (PPG) delivered earnings and revenue surprises of 17.42% and 2.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Amyris (AMRS) and Givaudan Close Cosmetic Ingredients Deal
by Zacks Equity Research
Amyris (AMRS) and Givaudan collaborate to leverage the former's technological platform for designing, scaling and manufacturing the best-performing bio-fermented ingredients.
Amyris (AMRS) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Record revenues in the Consumer segment drive Amyris' (AMRS) top line in the fourth quarter.
Amyris, Inc. (AMRS) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -160% and 27.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Ecolab (ECL) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Ecolab (ECL) delivered earnings and revenue surprises of 1.60% and 0.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Amyris, Inc. (AMRS) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -109.52% and 36.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Intrepid Potash (IPI) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Intrepid Potash (IPI) delivered earnings and revenue surprises of -37.42% and 4.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Axalta Coating Systems (AXTA) Meets Q3 Earnings Estimates
by Zacks Equity Research
Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 0% and 1.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Amyris, Inc. (AMRS) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -50% and 20.06%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 67.86% and 17.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Valvoline (VVV) Meets Q3 Earnings Estimates
by Zacks Equity Research
Valvoline (VVV) delivered earnings and revenue surprises of 0% and 0.95%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1
by Zacks Equity Research
Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.
Amyris, Inc. (AMRS) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -54.17% and 11.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for May 2nd
by Zacks Equity Research
ALEC, AMRS, and BLFS have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2022
Amyris, Inc. (AMRS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Amyris, Inc. (AMRS) closed the most recent trading day at $3.56, moving +1.42% from the previous trading session.
Amyris, Inc. (AMRS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Amyris, Inc. (AMRS) closed the most recent trading day at $4.48, moving +0.45% from the previous trading session.
New Strong Sell Stocks for March 24th
by Zacks Equity Research
GHM, AMRS, and GDOT have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2022
Amyris, Inc. (AMRS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Amyris, Inc. (AMRS) closed at $3.96 in the latest trading session, marking a +1.02% move from the prior day.
Amyris (AMRS) Q4 Earnings Lag Estimates, Sales Fall Y/Y
by Zacks Equity Research
Amyris (AMRS) sees strong revenues in its consumer segment in Q4 driven by the accelerated growth of its consumer brands.
Amyris (AMRS) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Amyris (AMRS) is likely to have benefited from continued strong growth in its consumer brands amid supply-chain headwinds in Q4.